Global Insulin Pen Market Inclinations And Development Status Highlighted During Forecast Period

SDKI Inc. published a new research report on "Global Insulin Pen Market-Forecast 2022-2030". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2022-2030 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-111564

The insulin pen market is estimated to reach US $ 128.5 million by 2030 from a market value of US $ 63.1 million in 2022 and is expected to grow at a CAGR of 10.7% during the 2022-2030 forecast period. increase.

Insulin pens are becoming more popular and many people with diabetes use them. Insulin levels are being administered or regulated. These pens enable easier, more accurate and accessible delivery than using syringes or vials. In many cases, few people prefer an insulin pen as a way to make taking insulin unobtrusive and inconvenient. Its low-cost availability also enhances its affordability and demand among individuals of all ages. Most pens come in two categories, including reusable insulin pens and disposable insulin pens. Prefilled insulin pens are a type of disposable pen that individuals prefer to inject insulin. The needle of an insulin pen is compact in size and thinner than a syringe.

Increasing prevalence of diabetes and obesity among individuals, as well as increased government support and reimbursement policies for diabetes management, are key factors driving the growth of the insulin pen market during the forecast period. According to the International Diabetes Federation (IDF), the number of people with diabetes worldwide is estimated to be about 436 million aged 20-79 in 2019. It also has the potential to grow at around 700 million by 2045. In addition, more than 60% of diabetics live in Asia and the Western Pacific. This has the potential to increase demand for insulin pens and thereby contribute to the growth of the insulin pen market around the world.

However, lack of proper knowledge of dosage levels and strict government regulations on patient safety may curb the growth of the insulin pen market during the 2022-2030 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-111564

Insulin pen market segment

The insulin pen market is divided by product type (disposable pens, reusable pens), by application (online pharmacies, hospital pharmacies, retail pharmacies), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of the Insulin Pen Market

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. North America is the world's leading region in terms of market share. This is due to the presence of a large pool of patients with diabetes and the wide range of market vendors in the region. Meanwhile, the Asia Pacific insulin pen market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030). Factors such as the rise of growing government programs for the management of obesity and diabetes, and improved medical infrastructure in developing countries such as China and India, provide favorable opportunities for the growth of the insulin pen market in the Asia-Pacific region. I am producing.

For further analysis, each region is further subdivided into countries:

· Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific)

· North America (US and Canada)

· Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)

· Latin America (Brazil, Mexico, Argentina, Other Latin America)

· Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia, Other Europe)

Key Players in the Insulin Pen Market

The key players in the insulin pen market are Becton, Dickinson and Company, Nova Nordisk, Inc., Vogt Medical Vertrieb GmbH, MedExel Co., Ltd., Owen Mumford Ltd., Perrigo Diabetes Care, LLC, HTL-STREFA, Inc., Sanofi SA, Eli Lilly and Company, Biocon Limited and more. The survey includes a detailed competitive analysis of these major companies in the insulin pen market, corporate profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/global-insulin-pen-market/330

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.